Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease - authors' reply

被引：1
作者：
Wang, W. [1 ]
Indik, S. [2 ]
Wong, G. K-S [1 ,3 ,4 ,5 ]
Mason, A. L. [1 ,5 ]
机构：
[1] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada
[2] Univ Vet Med, Dept Virol, Vienna, Austria
[3] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada
[4] BGI Shenzhen, Shenzhen, Peoples R China
[5] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2015年 / 41卷 / 05期
关键词：
CIRRHOSIS; VIRUS;
D O I：
10.1111/apt.13082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：491 / 491
页数：1
相关论文
共 48 条
[41]   Reply to: "FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)" [J].
Tsochatzis, Emmanuel A. ;
Srivastava, Ankur ;
Rosenberg, William .
JOURNAL OF HEPATOLOGY, 2021, 74 (01) :248-249
[42]   Reply to correspondence on "Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis" [J].
Zeng, Jing ;
Fan, Jian-Gao .
CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (02)
[43]   Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply [J].
Scheiner, Bernhard ;
Dominik, Nina ;
Mandorfer, Mattias .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (04) :542-543
[44]   Comparison between real-time tissue elastography and vibration-controlled transient elastography for the assessment of liver fibrosis and disease progression in patients with primary biliary cholangitis [J].
Koizumi, Yohei ;
Hirooka, Masashi ;
Abe, Masanori ;
Tokumoto, Yoshio ;
Yoshida, Osamu ;
Watanabe, Takao ;
Nakamura, Yoshiko ;
Imai, Yusuke ;
Yukimoto, Atsushi ;
Kumagi, Teru ;
Takeshita, Eiji ;
Ikeda, Yoshiou ;
Hiasa, Yoichi .
HEPATOLOGY RESEARCH, 2017, 47 (12) :1252-1259
[45]   Modified quick-SOFA score: Can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?: Editorial on "Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment" [J].
Incicco, Simone ;
Piano, Salvatore .
CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
[46]   A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on "Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis" [J].
Zeng, Jing ;
Fan, Jian-Gao .
CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (02)
[47]   Reply to: "Baveno VI elastography criteria for ruling in cACLD works well in patients with MAFLD" and "Transient elastography in chronic liver disease: Beware of the cut-offs!" [J].
Papatheodoridi, Margarita ;
Pinzani, Massimo ;
Tsochatzis, Emmanuel .
JOURNAL OF HEPATOLOGY, 2021, 75 (05) :1247-1247
[48]   Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on "Optimal cut-offs of vibration- controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis" [J].
Sohn, Won .
CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (01)
12345